TITLE

Development and Preliminary Randomized Controlled Trial of a Distress Tolerance Treatment for Smokers With a History of Early Lapse

AUTHOR(S)
Brown, Richard A.; Reed, Kathleen M. Palm; Bloom, Erika Litvin; Minami, Haruka; Strong, David R.; Lejuez, Carl W.; Kahler, Christopher W.; Zvolensky, Michael J.; Gifford, Elizabeth V.; Hayes, Steven C.
PUB. DATE
December 2013
SOURCE
Nicotine & Tobacco Research;Dec2013, Vol. 15 Issue 12, p2005
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Introduction: An inability to tolerate distress is a significant predictor of early smoking lapse following a cessation attempt. We conducted a preliminary randomized controlled trial to compare a distress tolerance (DT) treatment that incorporated elements of exposure-based therapies and Acceptance and Commitment Therapy to standard smoking cessation treatment (ST). Methods: Smokers with a history of early lapse in prior quit attempts received either DT (N = 27; 9 2-hr group and 6 50-min individual sessions) or ST (N = 22; 6 90-min group and 1 20-min individual session), plus 8 weeks of transdermal nicotine patch. Results: At the end of behavioral treatment, odds of abstinence among participants receiving DT were 6.46 times greater than among participants receiving ST (66.7% vs. 31.8%), equivalent to a medium- to large-effect size. Odds of abstinence for DT were still 1.73 times greater at 8 weeks, corresponding to a small- to medium-effect size, although neither this difference nor those at 13 and 26 weeks were statistically significant. Furthermore, of those who lapsed to smoking during the first week postquit, DT participants had more than 4 times greater odds of abstinence than ST participants at the end of treatment. Relative to ST, DT participants also reported a larger decrease in experiential avoidance, a hypothesized DT treatment mediator, prior to quit day. The trajectory of negative mood and withdrawal symptoms in DT differed from ST and was largely consistent with hypotheses. Conclusions: Reasons for the decrease in abstinence in DT after treatment discontinuation and suggestions for future research are discussed.
ACCESSION #
91961692

 

Related Articles

  • Examining the effects of initial smoking abstinence on response to smoking-related stimuli and response inhibition in a human laboratory model. Bradstreet, Matthew; Higgins, Stephen; McClernon, F.; Kozink, Rachel; Skelly, Joan; Washio, Yukiko; Lopez, Alexa; Parry, Marie // Psychopharmacology;May2014, Vol. 231 Issue 10, p2145 

    Rationale: Research is needed on initial smoking abstinence and relapse risk. Objective: This study aims to investigate the effects of different durations of initial abstinence on sensitivity to smoking-related stimuli and response inhibition in the context of a larger battery of outcome...

  • Treatment of cigarette smoking with short-term high-dosage corticotrophin therapy: preliminary communication. Bourne, Stephen // Journal of the Royal Society of Medicine;Aug1985, Vol. 78 Issue 8, p649 

    Uncontrolled studies have indicated that the smoker's ‘lift’ can be simulated clinically by short-term, high-dosage corticotrophin therapy. Following such treatment, smokers previously prevented by the withdrawal syndrome from giving up smoking were able to do so easily. All 10...

  • Smoking Cessation. Brender, Erin; Lyrim, Cassio; Class, Richard M. // JAMA: Journal of the American Medical Association;12/12/2007, Vol. 298 Issue 22, p2700 

    This article presents the patient education page which examines smoking cessation and offers advice on how to quit the habit. People who stop smoking decrease their risk of getting cancer, heart disease, stroke and early death. Women who stop smoking before or during pregnancy have a greater...

  • Effect of high-dose nicotine patch on craving and negative affect leading up to lapse episodes. Ferguson, Stuart; Shiffman, Saul // Psychopharmacology;Jul2014, Vol. 231 Issue 13, p2595 

    Rationale: Nicotine patches have been reliably demonstrated to improve smoking cessation outcomes but most users still lapse, and then relapse, during treatment. While patch has been shown to alleviate background cravings, its effects on cue-induced cravings - which have been linked to the...

  • Sustained Reduction of Nicotine Craving With Real-Time Neurofeedback: Exploring the Role of Severity of Dependence. Canterberry, Melanie; Hanlon, Colleen A.; Hartwell, Karen J.; Li, Xingbao; Owens, Max; LeMatty, Todd; Prisciandaro, James J.; Borckardt, Jeffrey; Saladin, Michael E.; Brady, Kathleen T.; George, Mark S. // Nicotine & Tobacco Research;Dec2013, Vol. 15 Issue 12, p2120 

    Background: Neurofeedback delivered via real-time functional magnetic resonance imaging (rtfMRI) is a promising therapeutic technique being explored to facilitate self-regulation of craving in nicotine-dependent cigarette smokers. The current study examined the role of nicotine-dependence...

  • Varenicline smokes the competition in the US.  // PharmacoEconomics & Outcomes News;5/31/2008, Issue 554, p5 

    The article reports that researchers from Great Britain and the U.S. have found that varenicline is a cost-effective alternative to the pharmacotherapies currently available for effective smoking cessation.

  • Enhancing the Effectiveness of Smoking Cessation Interventions: A Cancer Prevention Imperative. Alberg, Anthony J.; Carpenter, Matthew J. // JNCI: Journal of the National Cancer Institute;Feb2012, Vol. 104 Issue 4, p260 

    The article analyzes the effectiveness of smoking cessation interventions in addressing the epidemic of tobacco addiction in the U.S. and other developed countries. It discusses a reduction in the prevalence of smoking in the U.S. due to smoking cessation. It also documents the health benefits...

  • NEW HOPE for Smokers. Czech, Tina // Spa Australasia;2/ 1/2013, Vol. 52, p82 

    The article discusses the principles of laser auriculotherapy and its effect in relieving nicotine cravings. Auriculotherapy uses a special laser in stimulating invisible cutaneous points of lessened electrical resistance on the external surface of the ear. Study shows that the non-invasive...

  • Smoking Cessation--Part III: Pharmacotherapy of Smoking Cessation. Wilken, Lori; Corbridge, Susan J.; Simpson, Sandra // AAOHN Journal;Aug2005, Vol. 53 Issue 8, p340 

    Discusses the pharmacotherapy for smoking or tobacco habit. Withdrawal symptoms associated with quitting smoking; Types of medicine that can be use to quit smoking; Precautions when using nicotine replacement therapy.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics